Publications by authors named "David Verbel"

Claim this Profile
C
Clinical validation of the PrecivityAD2 blood test: A mass spectrometry-based test with algorithm combining %p-tau217 and Aβ42/40 ratio to identify presence of brain amyloid.
Matthew R Meyer, Kristopher M Kirmess, Stephanie Eastwood, Traci L Wente-Roth, Faith Irvin, David Verbel

Alzheimers Dement· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non-Muscle Invasive Murine Bladder Cancer.
Kuan-Chun Huang, Dinesh Chandra, Shannon McGrath, Vaishali Dixit, Chi Zhang, David Verbel

Mol Cancer Ther· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of cerebrospinal fluid biomarkers measured by LUMIPULSE system.
Hisashi Nojima, Satoshi Ito, Akira Kushida, Aki Abe, Wataru Motsuchi, David Verbel

Ann Clin Transl Neurol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non-Muscle Invasive Murine Bladder Cancer.
Kuan-Chun Huang, Dinesh Chanda, Shannon McGrath, Vaishali Dixit, Chi Zhang, David Verbel

Mol Cancer Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fully automated and highly specific plasma β-amyloid immunoassays predict β-amyloid status defined by amyloid positron emission tomography with high accuracy.
Kazuto Yamashita, Masahiro Miura, Shunsuke Watanabe, Kengo Ishiki, Yuji Arimatsu, David Verbel

Alzheimers Res Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive Impairment.
Yan Hu, Kristopher M Kirmess, Matthew R Meyer, Gil D Rabinovici, Constantine Gatsonis, David Verbel

JAMA Netw Open· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics, and preliminary efficacy of E6201 in patients with advanced solid tumours, including melanoma: results of a phase 1 study.
Raoul Tibes, Mitesh J Borad, Corina E Dutcus, Larisa Reyderman, Kevie Feit, David A Verbel

Br J Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of enzyme inhibition on perampanel pharmacokinetics: Why study design matters.
Barry E Gidal, Rama Maganti, Antonio Laurenza, Haichen Yang, David A Verbel

Epilepsy Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and excretion of (14)C-lenvatinib in patients with advanced solid tumors or lymphomas.
Anne-Charlotte Dubbelman, Hilde Rosing, Cynthia Nijenhuis, Alwin D R Huitema, Marja Mergui-Roelvink, David Verbel

Invest New Drugs· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, three-treatment, three-period, six-sequence-crossover, single-center, bioequivalence study to evaluate the impact of different 10-mg crystalline forms on the pharmacokinetics of lenvatinib in healthy volunteers.
Lucy Lee, Pina D'Angelo, David Verbel, Gresel Martinez, Jagadeesh Aluri

Int J Clin Pharmacol Ther· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systems pathology model for predicting overall survival in patients with refractory, advanced non-small-cell lung cancer treated with gefitinib.
Michael J Donovan, Angeliki Kotsianti, Valentina Bayer-Zubek, David Verbel, Mikhail Teverovskiy

Eur J Cancer· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of models to predict clinical failure after radical prostatectomy.
Scott E Eggener, Andrew J Vickers, Angel M Serio, Michael J Donovan, Faisal M Khan, David Verbel

Cancer· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifeature prostate cancer diagnosis and Gleason grading of histological images.
Ali Tabesh, Mikhail Teverovskiy, Ho-Yuen Pang, Vinay P Kumar, David Verbel

IEEE Trans Med Imaging· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclin D-1, interleukin-6, HER-2/neu, transforming growth factor receptor-II and prediction of relapse in women with early stage, hormone receptor-positive breast cancer treated with tamoxifen.
Hyman B Muss, Janice Yanushka Bunn, Abigail Crocker, Karen Plaut, James Koh, David Verbel

Breast J· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved prediction of prostate cancer recurrence through systems pathology.
Carlos Cordon-Cardo, Angeliki Kotsianti, David A Verbel, Mikhail Teverovskiy, Paola Capodieci

J Clin Invest· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer.
Susan F Slovin, Govind Ragupathi, Cristina Musselli, Celina Fernandez, Meghan Diani, David Verbel

Cancer Immunol Immunother· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy.
Michael J Morris, Timothy Akhurst, Steven M Larson, Marisa Ditullio, Elaina Chu, David Verbel

Clin Cancer Res· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of speech aid prostheses for acquired defects of the soft palate and velopharyngeal inadequacy--clinical assessments and cephalometric analysis: a Memorial Sloan-Kettering Study.
George Bohle, Jana Rieger, Joseph Huryn, David Verbel, Freeman Hwang

Head Neck· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prosthetic intervention in the era of microvascular reconstruction of the mandible--a retrospective analysis of functional outcome.
Khim H Teoh, Snehal Patel, Freeman Hwang, Joseph M Huryn, David Verbel

Int J Prosthodont· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of the tumor suppressor PML in human cancers of multiple histologic origins.
Carmela Gurrieri, Paola Capodieci, Rosa Bernardi, Pier Paolo Scaglioni, Khedoudja Nafa, David A Verbel

J Natl Cancer Inst· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine.
Susan F Slovin, Govindaswami Ragupathi, Cristina Musselli, Krystyna Olkiewicz, David Verbel

J Clin Oncol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p73 Expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancer.
Pere Puig, Paola Capodieci, Marija Drobnjak, David Verbel, Carol Prives

Clin Cancer Res· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma.
Paul A Hamlin, Andrew D Zelenetz, Tarun Kewalramani, Jing Qin, Jaya M Satagopan, David Verbel

Blood· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating survival benefit in castrate metastatic prostate cancer: decision making in proceeding to a definitive phase III trial.
David Andrew Verbel, W Kevin Kelly, Oren Smaletz, Kevin Regan, Tracy Curley

Urology· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of p63 expression is associated with tumor progression in bladder cancer.
Marshall J Urist, Charles J Di Como, Ming-Lan Lu, Elizabeth Charytonowicz, David Verbel

Am J Pathol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis